AAAAAA
Results:
1-8
|
Results: 8
Authors:
Pillonel, J
Courouce, AM
Saura, C
Desenclos, JC
Citation: J. Pillonel et al., Impact of the exclusion of donors having stayed in the United Kingdom on the residual risk of HIV transmission by blood transfusion., TRANSF CL B, 8(2), 2001, pp. 85-93
Authors:
Courouce, AM
Pillonel, J
Saura, C
Citation: Am. Courouce et al., Transmitted-transfusion infections. Screening in French blood donations from 1996 to 1998., TRANSF CL B, 7(2), 2000, pp. 153-170
Authors:
Bernillon, P
Lievre, L
Pillonel, J
Laporte, A
Costagliola, D
Citation: P. Bernillon et al., Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993, INT J EPID, 29(1), 2000, pp. 168-174
Authors:
Elghouzzi, MH
Bouchardeau, F
Pillonel, J
Boiret, E
Tirtaine, C
Barlet, V
Moncharmont, P
Maisonneuve, P
du Puy-Montbrun, MC
Lyon-Caen, D
Courouce, AM
Citation: Mh. Elghouzzi et al., Hepatitis C virus: Routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors, VOX SANGUIN, 79(3), 2000, pp. 138-144
Authors:
Bouchardeau, F
Laperche, S
Pillonel, J
Elghouzzi, MH
Maisonneuve, P
Tirtaine, C
Boiret, E
Razer, A
Girault, A
Beaulieu, MJ
Courouce, AM
Citation: F. Bouchardeau et al., GB Virus type C/HGV markers in HCV RNA-positive French blood donors: correlation with HCV genotypes and risk factors, TRANSFUSION, 40(7), 2000, pp. 875-878
Authors:
Saura, C
Courouce, AM
Pillonel, J
Costagliola, D
Flan, B
Defer, C
Coste, J
Rouzioux, C
Citation: C. Saura et al., Risk-benefit analysis of Nucleic Acid Testing: The French experience, BIOLOGICALS, 27(4), 1999, pp. 343-348
Authors:
Courouce, AM
Pillonel, J
Saura, C
Citation: Am. Courouce et al., Screening of blood donations for HTLV-I/II, TR MED REV, 13(4), 1999, pp. 267-274
Authors:
Desenclos, JC
Pillonel, J
Delarocque-Astagneau, E
de Valk, H
Citation: Jc. Desenclos et al., Epidemiology of hepatitis C and surveillance strategies., MED MAL INF, 29(5), 1999, pp. 325-331
Risultati:
1-8
|